Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1985-4-30
|
pubmed:abstractText |
A prospective study was performed on 22 patients with locally advanced transitional cell carcinoma of the urinary bladder to evaluate the toxicity and efficacy of an integrated treatment with cis-diamminedichloroplatinum (1.6 mg/kg body weight every 3 weeks for four cycles) and 60 G cobalt 60 or 18 MEV photons. Local and systemic toxicity caused by this treatment schedule was minor. Late sequelae consisted of contracted bladder in three patients. The rate of tumor-free bladders after a mean follow-up of 14 months was 17 of 22. Distant metastases occurred in three patients. Local recurrence of superficial tumor elsewhere in the bladder was observed in two patients. Six patients died 4 to 10 months after initiation of the integrated therapy, three of these without evidence of disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1659-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4038912-Aged,
pubmed-meshheading:4038912-Carcinoma, Transitional Cell,
pubmed-meshheading:4038912-Cisplatin,
pubmed-meshheading:4038912-Combined Modality Therapy,
pubmed-meshheading:4038912-Female,
pubmed-meshheading:4038912-Humans,
pubmed-meshheading:4038912-Male,
pubmed-meshheading:4038912-Middle Aged,
pubmed-meshheading:4038912-Neoplasm Metastasis,
pubmed-meshheading:4038912-Neoplasm Recurrence, Local,
pubmed-meshheading:4038912-Neoplasm Staging,
pubmed-meshheading:4038912-Prospective Studies,
pubmed-meshheading:4038912-Teniposide,
pubmed-meshheading:4038912-Tomography, X-Ray Computed,
pubmed-meshheading:4038912-Urinary Bladder Neoplasms
|
pubmed:year |
1985
|
pubmed:articleTitle |
Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder.
|
pubmed:publicationType |
Journal Article
|